MOACM
AMPH icon

Mutual of America Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Mutual of America Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-92,251
Closed -$3.43M – 1415
2024
Q4 		$3.43M Sell
92,251
-106
-0.1% -$4.85K 0.04% 638
2024
Q3 		$4.48M Sell
92,357
-1,372
-1% -$60.2K 0.05% 519
2024
Q2 		$3.75M Sell
93,729
-3,954
-4% -$164K 0.04% 595
2024
Q1 		$4.29M Buy
97,683
+9,926
+11% +$513K 0.05% 558
2023
Q4 		$5.43M Sell
87,757
-3,813
-4% -$200K 0.06% 394
2023
Q3 		$4.21M Sell
91,570
-18,616
-17% -$1.02M 0.05% 500
2023
Q2 		$6.33M Sell
110,186
-937
-0.8% -$41.5K 0.07% 316
2023
Q1 		$4.17M Sell
111,123
-4,904
-4% -$161K 0.05% 560
2022
Q4 		$3.25M Buy
116,027
+32,777
+39% +$952K 0.04% 687
2022
Q3 		$2.34M Buy
83,250
+76,936
+1,218% +$2.51M 0.03% 774
2022
Q2 		$220K Buy
6,314
+1,005
+19% +$35.9K ﹤0.01% 1299
2022
Q1 		$191K Buy
5,309
+275
+5% +$7.8K ﹤0.01% 1364
2021
Q4 		$117K Buy
5,034
+103
+2% +$2.11K ﹤0.01% 1494
2021
Q3 		$94K Sell
4,931
-284
-5% -$5.56K ﹤0.01% 1544
2021
Q2 		$105K Buy
5,215
+330
+7% +$6.22K ﹤0.01% 1557
2021
Q1 		$89K Buy
4,885
+315
+7% +$5.86K ﹤0.01% 1571
2020
Q4 		$92K Buy
4,570
+169
+4% +$3.29K ﹤0.01% 1496
2020
Q3 		$83K Buy
4,401
+2,760
+168% +$55.6K ﹤0.01% 1432
2020
Q2 		$37K Buy
1,641
+134
+9% +$2.45K ﹤0.01% 1416
2020
Q1 		$22K Buy
1,507
+279
+23% +$4.85K ﹤0.01% 1467
2019
Q4 		$24K Sell
1,228
-51
-4% -$978 ﹤0.01% 1530
2019
Q3 		$25K Buy
1,279
+19
+2% +$396 ﹤0.01% 1519
2019
Q2 		$27K Buy
1,260
+262
+26% +$5.48K ﹤0.01% 1497
2019
Q1 		$20K Buy
998
+135
+16% +$3.02K ﹤0.01% 1520
2018
Q4 		$17K Buy
863
+205
+31% +$4.04K ﹤0.01% 1502
2018
Q3 		$13K Buy
658
+526
+398% +$9.38K ﹤0.01% 1572
2018
Q2 		$2K Buy
+132
New +$2.31K ﹤0.01% 1584

Other funds holding AMPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mutual of America Capital Management's AMPH Position: Q1 2025 in Review

Mutual of America Capital Management sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2025, closing a stake of 92,251 shares — an estimated $3.43M sold.

Mutual of America Capital Management first reported a position in AMPH in Q2 2018 and held it in 27 quarters. The position peaked at $6.33M in Q2 2023. 241 funds tracked by Wall St. Rank hold AMPH as of Q1 2025.

  • Mutual of America Capital Management reported no remaining Amphastar Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Mutual of America Capital Management sold 92,251 Amphastar Pharmaceuticals shares in Q1 2025, an estimated $3.43M.
  • Mutual of America Capital Management first reported a position in Amphastar Pharmaceuticals in Q2 2018 and held it in 27 quarters.
  • Mutual of America Capital Management's Amphastar Pharmaceuticals position peaked at $6.33M in Q2 2023.
  • 241 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2025.

Based on Mutual of America Capital Management's 13F filing for Q1 2025, filed 1 May 2025.